Literature DB >> 3057399

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.

C Brodeur1, J Montplaisir, R Godbout, R Marinier.   

Abstract

Six patients with restless legs syndrome (RLS) and periodic movements during sleep (PMS) received placebo or L-dopa in a double-blind study. We recorded patients for 36 consecutive hours in the sleep laboratory during a baseline investigation and at the end of each treatment period. Daily evening questionnaires and a suggested immobilization test (SIT) performed at bedtime on each recording night documented the effect of L-dopa in RLS. A nocturnal EMG recording of the anterior tibialis muscles revealed the effect of L-dopa on PMS. L-Dopa proved effective in treating both RLS and PMS. Although not present in every patient, leg movements recorded during the SIT exhibited a clear periodicity. These observations support the hypothesis that RLS and PMS are two manifestations of the same central sensorimotor disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3057399     DOI: 10.1212/wnl.38.12.1845

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Restless Legs Syndrome.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

2.  Myoclonus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 3.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

4.  Clinical correlates of periodic limb movements in sleep in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Jeanne Maglione; Sonia Ancoli-Israel
Journal:  J Neurol Sci       Date:  2012-01-25       Impact factor: 3.181

5.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 6.  The treatment of sundowning. A selective review of pharmacological and nonpharmacological studies.

Authors:  S McGaffigan; D L Bliwise
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

7.  Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.

Authors:  J Staedt; F Wassmuth; U Ziemann; G Hajak; E Rüther; G Stoppe
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

8.  Drug-related Sleep Stage Changes: Functional Significance and Clinical Relevance.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Sleep Med Clin       Date:  2010-12-01

9.  Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus).

Authors:  J Staedt; G Stoppe; A Kögler; D Munz; H Riemann; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  A case of a patient with both chorea and restless legs syndrome.

Authors:  Yoon-Kyung Shin; Seung-Chul Hong; Yon Kwon Ihn; Jong-Hyun Jeong; Jin-Hee Han; Sung-Pil Lee
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.